These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 33660195

  • 1. Genomic Landscape and Risk Stratification in Chronic Myelomonocytic Leukemia.
    Hunter A, Padron E.
    Curr Hematol Malig Rep; 2021 Jun; 16(3):247-255. PubMed ID: 33660195
    [Abstract] [Full Text] [Related]

  • 2. Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia.
    Patnaik MM, Tefferi A.
    Blood Cancer J; 2016 Feb 05; 6(2):e393. PubMed ID: 26849014
    [Abstract] [Full Text] [Related]

  • 3. Mutations in chronic myelomonocytic leukemia and their prognostic relevance.
    Jian J, Qiao Y, Li Y, Guo Y, Ma H, Liu B.
    Clin Transl Oncol; 2021 Sep 05; 23(9):1731-1742. PubMed ID: 33861431
    [Abstract] [Full Text] [Related]

  • 4. Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features.
    Palomo L, Garcia O, Arnan M, Xicoy B, Fuster F, Cabezón M, Coll R, Ademà V, Grau J, Jiménez MJ, Pomares H, Marcé S, Mallo M, Millá F, Alonso E, Sureda A, Gallardo D, Feliu E, Ribera JM, Solé F, Zamora L.
    Oncotarget; 2016 Aug 30; 7(35):57021-57035. PubMed ID: 27486981
    [Abstract] [Full Text] [Related]

  • 5. Genomic determinants of chronic myelomonocytic leukemia.
    Patel BJ, Przychodzen B, Thota S, Radivoyevitch T, Visconte V, Kuzmanovic T, Clemente M, Hirsch C, Morawski A, Souaid R, Saygin C, Nazha A, Demarest B, LaFramboise T, Sakaguchi H, Kojima S, Carraway HE, Ogawa S, Makishima H, Sekeres MA, Maciejewski JP.
    Leukemia; 2017 Dec 30; 31(12):2815-2823. PubMed ID: 28555081
    [Abstract] [Full Text] [Related]

  • 6. When clinical heterogeneity exceeds genetic heterogeneity: thinking outside the genomic box in chronic myelomonocytic leukemia.
    Ball M, List AF, Padron E.
    Blood; 2016 Nov 17; 128(20):2381-2387. PubMed ID: 27707735
    [Abstract] [Full Text] [Related]

  • 7. Chronic Myelomonocytic Leukemia: a Genetic and Clinical Update.
    McCullough KB, Patnaik MM.
    Curr Hematol Malig Rep; 2015 Sep 17; 10(3):292-302. PubMed ID: 26122388
    [Abstract] [Full Text] [Related]

  • 8. Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia.
    Elena C, Gallì A, Such E, Meggendorfer M, Germing U, Rizzo E, Cervera J, Molteni E, Fasan A, Schuler E, Ambaglio I, Lopez-Pavia M, Zibellini S, Kuendgen A, Travaglino E, Sancho-Tello R, Catricalà S, Vicente AI, Haferlach T, Haferlach C, Sanz GF, Malcovati L, Cazzola M.
    Blood; 2016 Sep 08; 128(10):1408-17. PubMed ID: 27385790
    [Abstract] [Full Text] [Related]

  • 9. Genomics of myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes.
    Patnaik MM, Lasho TL.
    Hematology Am Soc Hematol Educ Program; 2020 Dec 04; 2020(1):450-459. PubMed ID: 33275756
    [Abstract] [Full Text] [Related]

  • 10. Prognostic score including gene mutations in chronic myelomonocytic leukemia.
    Itzykson R, Kosmider O, Renneville A, Gelsi-Boyer V, Meggendorfer M, Morabito M, Berthon C, Adès L, Fenaux P, Beyne-Rauzy O, Vey N, Braun T, Haferlach T, Dreyfus F, Cross NC, Preudhomme C, Bernard OA, Fontenay M, Vainchenker W, Schnittger S, Birnbaum D, Droin N, Solary E.
    J Clin Oncol; 2013 Jul 01; 31(19):2428-36. PubMed ID: 23690417
    [Abstract] [Full Text] [Related]

  • 11. 3q26/EVI1 rearrangement in myelodysplastic/myeloproliferative neoplasms: An early event associated with a poor prognosis.
    Hu Z, Hu S, Ji C, Tang Z, Thakral B, Loghavi S, Medeiros LJ, Wang W.
    Leuk Res; 2018 Feb 01; 65():25-28. PubMed ID: 29288910
    [Abstract] [Full Text] [Related]

  • 12. Clinical Applications of Chromosomal Microarray Testing in Myeloid Malignancies.
    Ronaghy A, Yang RK, Khoury JD, Kanagal-Shamanna R.
    Curr Hematol Malig Rep; 2020 Jun 01; 15(3):194-202. PubMed ID: 32382988
    [Abstract] [Full Text] [Related]

  • 13. Targeted sequencing aids in identifying clonality in chronic myelomonocytic leukemia.
    Hwang SM, Kim SM, Nam Y, Kim J, Kim S, Ahn YO, Park Y, Yoon SS, Shin S, Kwon S, Lee DS.
    Leuk Res; 2019 Sep 01; 84():106190. PubMed ID: 31377458
    [Abstract] [Full Text] [Related]

  • 14. Chronic myelomonocytic leukemia: 2022 update on diagnosis, risk stratification, and management.
    Patnaik MM, Tefferi A.
    Am J Hematol; 2022 Mar 01; 97(3):352-372. PubMed ID: 34985762
    [Abstract] [Full Text] [Related]

  • 15. Genetic and epigenetic factors interacting with clonal hematopoiesis resulting in chronic myelomonocytic leukemia.
    Carr RM, Patnaik MM.
    Curr Opin Hematol; 2020 Jan 01; 27(1):2-10. PubMed ID: 31688455
    [Abstract] [Full Text] [Related]

  • 16. Genetic complexity of chronic myelomonocytic leukemia.
    Patel AB, Deininger MW.
    Leuk Lymphoma; 2021 May 01; 62(5):1031-1045. PubMed ID: 33337259
    [Abstract] [Full Text] [Related]

  • 17. Molecular genetics of MDS/MPN overlap syndromes.
    Hunter AM, Padron E.
    Best Pract Res Clin Haematol; 2020 Sep 01; 33(3):101195. PubMed ID: 33038984
    [Abstract] [Full Text] [Related]

  • 18. Chronic myelomonocytic leukemia and atypical chronic myeloid leukemia: novel pathogenetic lesions.
    Muramatsu H, Makishima H, Maciejewski JP.
    Semin Oncol; 2012 Feb 01; 39(1):67-73. PubMed ID: 22289493
    [Abstract] [Full Text] [Related]

  • 19. Recent Updates on Chronic Myelomonocytic Leukemia.
    Loghavi S, Khoury JD.
    Curr Hematol Malig Rep; 2018 Dec 01; 13(6):446-454. PubMed ID: 30311069
    [Abstract] [Full Text] [Related]

  • 20. Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management.
    Patnaik MM, Tefferi A.
    Am J Hematol; 2024 Jun 01; 99(6):1142-1165. PubMed ID: 38450850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.